诺为泰发布小细胞肺癌全球临床试验概况综合报告

<!DOCTYPE html> <html lang="zh" xmlns:wb="//open.weibo.com/wb"> <head> <meta charset="utf-8"> <title>诺为泰发布小细胞肺癌全球临床试验概况综合报告 - 美国商业资讯</title> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="description" content="旧金山--(美国商业资讯)--作为一家可提供全方位服务的国际性临床合同研究组织 (CRO)，Novotech（诺为泰）发布了一份新报告《小细胞肺癌：全球临床试验概况（2024年）》。该报告对全球小细胞肺癌 (SCLC) 临床试验的现状、挑战和机遇进行了深入分析。本新闻稿包含多媒体。此"> <meta name="keywrods" content=""> <meta name="author" content="Business Wire China"> <link href="/css/bootstrap.css" rel="stylesheet"> <link href="/css/main.css?ver=20220804" rel="stylesheet"> <link href="/css/bootstrap-responsive.css" rel="stylesheet"> <script type="text/javascript" src="/js/jquery.min.js"></script> <script type="text/javascript" src="/js/bootstrap.js"></script> <script type="text/javascript" src="/js/main.js"></script>  <script src="//tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script> </head> <body>  <div class="header"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <div class="top_panel visible-desktop"> <a href="/zh">简体中文</a> | <a href="/hk">繁體中文</a> | <a href="/en">English</a> <div class="globalsite"><select id="globalsite" class="languages"><option value="0">美国商业资讯全球站点</option> <option value="1">Business Wire Global</option><option value="3">UK/Ireland</option><option value="4">Deutschland</option><option value="5">France</option><option value="6">Italy</option><option value="7">Japan</option> </select> </div> </div> <div class="logo"><a href="/zh"><img src="/images/bwlogo_webmain_china.png" alt="美国商业资讯" width="360" height="80"/></a></div> <div class="clear"></div> <div class="navigation"> <ul class="sf-menu"> <li class="current"><a href="/zh">首页</a> </li> <li><a href="/zh/news/index.html">新闻稿中心</a> </li> <li><a href="/zh/events/index.html">会展信息</a> </li> <li><a href="/zh/medias/index.html">媒体合作</a> </li> <li><a href="/zh/about/index.html">美国商业资讯</a> <ul> <li><a href="/zh/about/contact.html">联系我们</a></li> </ul> </li> </ul> <div class="clear"></div>  <div class="search_form visible-desktop"> <form action="/zh/news/search.html" method="get"> <input class="inp_search" name="s" type="text" value="搜索..." title="搜索..." /> <input type="submit" class="search_btn" value=" " /> </form> </div>  </div>  </div> </div> </div> </div>   <div class="page_wrapper"> <div class="wrap"> <div class="container"> <div id="content"> <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js?appkey=3616646312" type="text/javascript" charset="utf-8"></script> <script type="text/javascript" src="/js/swfobject.js"></script> <div class="full_980 main_wrap"> <div class="row"> <div class="span9 main_block story"> <p><img src="/files/logos/N/Novotech-TM-Verticle-logo-navy-new-tag.jpg" alt="Novotech"></p> <h2 class="storytitle">诺为泰发布小细胞肺癌全球临床试验概况综合报告</h2> <div class="storytimelang"> <span class="time">2024-11-19 10:12</span> <span class="lang"> <ul> <li><a href="/zh/news/58335.html"><img src="/images/zh_cn.png" alt="zh_cn"></a></li> <li><a href="/hk/news/58335.html"><img src="/images/zh_hant.png" alt="zh_hant"></a></li> <li><a href="/en/news/58335.html"><img src="/images/en.png" alt="en"></a></li> </ul> </span> <div class="clear"></div> </div> <ul class="industry-list"> <li><a href="/zh/industry/health-pharmaceutical.html" class="btn">医药和健康</a></li> </ul> <div class="storycontent"> <p> 旧金山--(美国商业资讯)--作为一家可提供全方位服务的国际性临床合同研究组织 (CRO)，Novotech（诺为泰）发布了一份新报告《<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Freports%2Fsmall-cell-lung-cancer-global-clinical-trial-landscape-2024%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Sep_SCLC_DR_CHS%26utm_id%3D701Oc00000D9W9NIAV&esheet=54151105&newsitemid=20241118104856&lan=zh-CN&anchor=%26%2323567%3B%26%2332454%3B%26%2332990%3B%26%2332954%3B%26%2330284%3B%26%2365306%3B%26%2320840%3B%26%2329699%3B%26%2320020%3B%26%2324202%3B%26%2335797%3B%26%2339564%3B%26%2327010%3B%26%2320917%3B%26%2365288%3B2024%26%2324180%3B%26%2365289%3B&index=1&md5=06923cd3efb9f2181a1ceeae6616d312"><em>小细胞肺癌：全球临床试验概况（2024</em><em>年）</em></a>》。该报告对全球小细胞肺癌 (SCLC) 临床试验的现状、挑战和机遇进行了深入分析。</p> <p> 本新闻稿包含多媒体。此处查看新闻稿全文： <a href="https://www.businesswire.com/news/home/20241118104856/zh-CN/">https://www.businesswire.com/news/home/20241118104856/zh-CN/</a></p> <p> 报告提供了关于肿瘤学的重要见解，凸显了诺为泰致力于推进治疗研究的承诺。</p> <p> <strong>报告的重要内容包括：</strong></p> <ul> <li> <strong>流行病学和发病率分布</strong>：本部分分析了小细胞肺癌的全球分布情况，其中亚洲的发病率较高 (63%)，其次是欧洲和北美。本部分对于制定区域特定试验和招募策略至关重要。</li> <li> <strong>药物开发管线</strong>：本部分概述了小细胞肺癌管线药物，重点介绍了免疫检查点抑制剂和靶向疗法等创新疗法。本部分还强调了管线药物的多阶段发展以及免疫疗法在小细胞肺癌治疗中日益重要的作用。</li> <li> <strong>资金和投资概况</strong>：本部分梳理了公共和私人资金趋势，指出对小细胞肺癌的风险投资有所增加。该风险投资主要源于中国和美国，反映出新兴疗法具有庞大的市场潜力。</li> <li> <strong>不断优化的治疗策略</strong>：本部分回顾了先进治疗方案，其中涵盖放射疗法、基因疗法和个性化疗法，强调了精准医疗在改善小细胞肺癌患者结局中的关键作用。</li> <li> <strong>运营挑战与解决方案</strong>：本部分探讨了小细胞肺癌试验的复杂性，如受试者招募和监管合规性，尤其是多区域研究的合规性。</li> </ul> <p> 下载完整报告，深入了解小细胞肺癌试验的未来趋势以及利用这些趋势获得临床成功的策略。</p> <p> <strong>【</strong><a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Freports%2Fsmall-cell-lung-cancer-global-clinical-trial-landscape-2024%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Sep_SCLC_DR_CHS%26utm_id%3D701Oc00000D9W9NIAV&esheet=54151105&newsitemid=20241118104856&lan=zh-CN&anchor=%26%2328857%3B%26%2320987%3B%26%2327492%3B%26%2322788%3B%26%2319979%3B%26%2336733%3B%26%2325253%3B%26%2321578%3B&index=2&md5=6897d58699e8dabedd76ce1cbbfc66d1"><strong>点击此处下载报告</strong></a><strong>】</strong></p> <p> 关于诺为泰<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Fabout%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Sep_SCLC_DR_CHS%26utm_id%3D701Oc00000D9W9NIAV&esheet=54151105&newsitemid=20241118104856&lan=zh-CN&anchor=Novotech-CRO.com&index=3&md5=ed97eed80211fe79f6c6dc1f99f7acb6">Novotech-CRO.com</a></p> <p> <strong>Novotech（诺为泰）成立于1997年，是一家可提供全方位服务的专业生物技术合同研究组织（CRO），致力于加速临床各个阶段创新药物和先进疗法的开发。</strong></p> <p> 诺为泰因其在行业内的突出贡献而备受赞誉，曾荣获多项殊荣，其中包括弗若斯特沙利文2024年全球生物技术CRO奖 (Frost & Sullivan 2024 Global Biotech CRO Award)、2024年临床试验竞技场卓越奖 (Clinical Trials Arena Excellence Awards 2024)、2024年优选雇主 (2024 Employer of Choice)、2024年美国Great Place to Work（卓越职场）认证 (2024 Great Place to Work in the US)、2024年布兰登·霍尔专业能力和技能发展金奖 (2024 Brandon Hall Gold Award)、2023年CRO领导力奖 (CRO Leadership Award 2023)、2023年亚太地区细胞与基因治疗临床试验卓越奖 (Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023) 和自2006年以来蝉联亚太地区合同研究组织年度公司奖 (Asia-Pacific Contract Research Organization Company of the Year Award)。</p> <p> 诺为泰是一家包含实验室、Ⅰ期临床中心、药物开发咨询和专业法规服务的临床CRO，拥有超5,000 项临床项目经验，包括Ⅰ期至Ⅳ期临床试验和生物等效性研究。诺为泰目前在全球34个办公地点共拥有3000多名员工，是值得信赖的战略合作伙伴。</p> <p> 要了解更多信息或与专家团队成员交谈，请访问<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnovotech-cro.com%2Fcn%2Ftalk-to-an-expert%3Futm_source%3DBusiness%2BWire%26utm_medium%3DPress%2BRelease%26utm_campaign%3D2024_Sep_SCLC_DR_CHS%26utm_id%3D701Oc00000D9W9NIAV&esheet=54151105&newsitemid=20241118104856&lan=zh-CN&anchor=www.Novotech-CRO.com&index=4&md5=bad6016f54d65ef18253c2e2a962a375">www.Novotech-CRO.com</a></p> <p> 在 businesswire.com 上查看源版本新闻稿: <a href="https://www.businesswire.com/news/home/20241118104856/zh-CN/">https://www.businesswire.com/news/home/20241118104856/zh-CN/</a></p> <p> <strong>CONTACT: </strong></p> <p> <strong>媒体联系信息 </strong><br /> <strong>Toyna Chin </strong><br /> <a href="mailto:mediacontact@novotech-cro.com"><strong>mediacontact@novotech-cro.com </strong></a><br /> 美国：+1 415 364 8135</p> <div class="story-image"> <img src="/files/news/54151105-1731982685-1.jpg" alt="Novotech关于小细胞肺癌全球临床试验格局的信息图"/> <p class="caption">Novotech关于小细胞肺癌全球临床试验格局的信息图</p> </div> </div> <div class="subjects"> <ul class="subject-list"> <li><a href="/zh/subject/products-services.html">产品服务</a></li> </ul> </div>  <div id="ckepop"> <span class="jiathis_txt">分享到：    </span> <a class="jiathis_button_tsina"></a> <a class="jiathis_button_tqq"></a> <a class="jiathis_button_renren"></a> <a class="jiathis_button_kaixin001"></a> <a class="jiathis_button_tsohu"></a> <a class="jiathis_button_t163"></a> <a class="jiathis_button_fb"></a> <a class="jiathis_button_googleplus"></a> <a class="jiathis_button_tifeng"></a> <a class="jiathis_button_thexun"></a> <a class="jiathis_button_cnfol"></a> <a class="jiathis_button_txinhua"></a> <a class="jiathis_button_linkedin"></a> <a href="http://www.jiathis.com/share" class="jiathis jiathis_txt jtico jtico_jiathis" target="_blank"></a> </div> <script type="text/javascript" src="http://v3.jiathis.com/code/jia.js?uid=1344225902068353" charset="utf-8"></script> <div class="clear"></div> <div class="commentbox"> <wb:comments url="auto" border="y" width="auto" skin="blue" appkey="3616646312" ></wb:comments> </div> </div> <div class="span3 sidebar"> <div class="widget"> <h3>美国商业资讯微博</h3> <wb:follow-button uid="2676312451" type="red_2" width="136" height="24" ></wb:follow-button> </div> <div class="widget"> <h3>新闻稿中心</h3> <ul class="industry"> <li><a href="/zh/industry/corporate-social-responsibility">企业社会责任</a></li> <li><a href="/zh/industry/manufacturing">制造业</a></li> <li><a href="/zh/industry/chemical">化工</a></li> <li><a href="/zh/industry/health-pharmaceutical">医药和健康</a></li> <li><a href="/zh/industry/property">建筑和房地产</a></li> <li><a href="/zh/industry/travel">旅游</a></li> <li><a href="/zh/industry/automotive">汽车</a></li> <li><a href="/zh/industry/life-entertainment">生活和娱乐</a></li> <li><a href="/zh/industry/energy-environmental">能源和环境</a></li> <li><a href="/zh/industry/retail">零售</a></li> <li><a href="/zh/industry/transportation">运输和物流</a></li> <li><a href="/zh/industry/business-ecommerce">商务</a></li> <li><a href="/zh/industry/communications-media">通信和传媒</a></li> <li><a href="/zh/industry/metals-mining">金属和矿产</a></li> <li><a href="/zh/industry/finance">金融</a></li> <li><a href="/zh/industry/technology">高科技</a></li> <li><a href="/zh/industry/sports">体育</a></li> <li><a href="/zh/industry/education">教育</a></li> <li><a href="/zh/industry/art-culture">艺术文化</a></li> <li><a href="/zh/industry/legal">法律</a></li> </ul> </div> <div class="widget"> <h3>最新新闻稿</h3> <ul class="story"> <li><span class="time">2024-11-22 16:15</span><br/><a href="/zh/news/58380.html">SIAL Paris 2024：迎来60周年庆的非凡盛会</a></li> <li><span class="time">2024-11-22 15:12</span><br/><a href="/zh/news/58378.html">Rigaku在美国开设生物科学实验室</a></li> <li><span class="time">2024-11-22 14:59</span><br/><a href="/zh/news/58377.html">PUMA发布新播客“绿色旗帜”：让Z世代参与可持续发展</a></li> <li><span class="time">2024-11-22 14:50</span><br/><a href="/zh/news/58376.html">Moody’s收购Numerated Growth Technologies，拓展贷款技术解决方案</a></li> <li><span class="time">2024-11-22 11:17</span><br/><a href="/zh/news/58375.html">Andersen在10个亚太国家和地区推进全球估值业务</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </div>   <div id="footer" class="hidden-phone"> <div class="wrap"> <div class="container"> <div class="full_980 relative">  <a href="#" id="totop_btn" class="visible-desktop visible-tablet" title="回到顶端"></a>   <div class="footer_top"> <div class="col940"> <div class="row"> <div class="span4"> <h4>上海</h4> <p class="foot_home">上海市江宁路167号新城大厦1502室</p> <p class="foot_phone">+86 21 5239 8905</p> <p class="foot_email"><a href="mailto:sh@businesswirechina.com">sh@businesswirechina.com</a></p> </div> <div class="span4"> <h4>Business Wire Hong Kong</h4> <p class="foot_home">51/F Hopewell Centre, 183 Queen's Road East<br/>Wan Chai, Hong Kong</p> <p class="foot_phone">+852 3602 3091</p> <p class="foot_email"><a href="mailto:hk@businesswire.com">hk@businesswire.com</a></p> </div> <div class="span4"> <h4 style="text-align: center;text-transform:none;">官方微信：Interfax_China</h4> <p style="text-align: center;"><img src="/images/wechat-bwchina.jpg" style="width:160px" alt="官方微信：Interfax_China"/> </p> </div> </div> </div> </div> <div class="footer_bottom"> <div class="fleft"> <div class="copyright">© 2008-2018 Interfax Business Wire Services 版权所有，未经许可不得转载。</div> </div> <div class="clear"></div> </div>  </div> </div> </div> </div> <script type="text/javascript"> var _gaq = _gaq || []; _gaq.push(['_setAccount', 'UA-669196-13']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); </script> <script language="javascript"> $(document).ready(function() { $("#globalsite").bind("change",function(){ var links = ['','http://www.businesswire.com','http://www.businesswire.ca/','http://www.businesswire.co.uk/','http://www.businesswire.de/','http://www.businesswire.fr/','http://www.businesswire.it/','http://www.businesswire.jp/']; var val = $(this).val(); var link = links[val]; if(link.length>0) { window.open(link); } }); }); </script> </body> </html>

CINXE.COM

诺为泰发布小细胞肺癌全球临床试验概况综合报告 - 美国商业资讯